BIONIME USA CORPORATION

Bionime Corporation is a Taiwan-based medical device manufacturer (founded 2003, publicly listed 2007) specializing in blood glucose management systems for personal and professional use. The company designs, manufactures, and markets Blood Glucose Meters (BGM), Continuous Glucose Monitoring (CGM) systems, Point-of-Care Testing (POCT) devices, and related consumables including test strips and lancing devices. Bionime has developed a proprietary cloud-based ecosystem branded RIGHTEST, utilizing IoT-enabled digital solutions to integrate product data with customer service and market intelligence for comprehensive diabetes management. With 480+ core CGM patents, Industry 4.0 manufacturing capabilities, and self-built software integration, Bionime operates globally through subsidiaries in Australia and Shenzhen, distributing to United States, Europe, and multiple international markets. The company targets both individual patients and healthcare institutions, positioning affordable, high-quality blood glucose control solutions to prevent diabetes-related complications.